View in EDS

Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.

Saved in:
Bibliographic Details
Title: Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.
Authors: Sirard JC; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Cayet D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Fougeron D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Soulard D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Tabareau J; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France., Hot D; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Santé, F-59000 Lille, France., Barnier-Quer C; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland., Jakob V; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland., Collin N; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland; Vaccine Formulation Institute, CH-1228 Plan-les-Ouates, Switzerland., Mollenkopf HJ; Max Planck Institute for Infection Biology, D-10117 Berlin, Germany., Stockhofe-Zurwieden N; Wageningen Bioveterinary Research, Wageningen University & Research, NL-8221 Lelystad, the Netherlands., Van Maele L; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: laurye.van-maele@inserm.fr.
Source: Vaccine [Vaccine] 2026 Apr 30; Vol. 80, pp. 128543. Date of Electronic Publication: 2026 Apr 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41936262
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sirard+JC%22">Sirard JC</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.<br /><searchLink fieldCode="AU" term="%22Cayet+D%22">Cayet D</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.<br /><searchLink fieldCode="AU" term="%22Fougeron+D%22">Fougeron D</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.<br /><searchLink fieldCode="AU" term="%22Soulard+D%22">Soulard D</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.<br /><searchLink fieldCode="AU" term="%22Tabareau+J%22">Tabareau J</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.<br /><searchLink fieldCode="AU" term="%22Hot+D%22">Hot D</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS - Plateformes Lilloises de Biologie & Santé, F-59000 Lille, France.<br /><searchLink fieldCode="AU" term="%22Barnier-Quer+C%22">Barnier-Quer C</searchLink>; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jakob+V%22">Jakob V</searchLink>; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Collin+N%22">Collin N</searchLink>; Vaccine Formulation Laboratory, University of Lausanne, CH-1066 Epalinges, Switzerland; Vaccine Formulation Institute, CH-1228 Plan-les-Ouates, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mollenkopf+HJ%22">Mollenkopf HJ</searchLink>; Max Planck Institute for Infection Biology, D-10117 Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Stockhofe-Zurwieden+N%22">Stockhofe-Zurwieden N</searchLink>; Wageningen Bioveterinary Research, Wageningen University & Research, NL-8221 Lelystad, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Van+Maele+L%22">Van Maele L</searchLink>; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: laurye.van-maele@inserm.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2026 Apr 30; Vol. 80, pp. 128543. <i>Date of Electronic Publication: </i>2026 Apr 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41936262
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2026.128543
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 128543
    Titles:
      – TitleFull: Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sirard JC
      – PersonEntity:
          Name:
            NameFull: Cayet D
      – PersonEntity:
          Name:
            NameFull: Fougeron D
      – PersonEntity:
          Name:
            NameFull: Soulard D
      – PersonEntity:
          Name:
            NameFull: Tabareau J
      – PersonEntity:
          Name:
            NameFull: Hot D
      – PersonEntity:
          Name:
            NameFull: Barnier-Quer C
      – PersonEntity:
          Name:
            NameFull: Jakob V
      – PersonEntity:
          Name:
            NameFull: Collin N
      – PersonEntity:
          Name:
            NameFull: Mollenkopf HJ
      – PersonEntity:
          Name:
            NameFull: Stockhofe-Zurwieden N
      – PersonEntity:
          Name:
            NameFull: Van Maele L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 04
              Text: 2026 Apr 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 80
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1